Ignite Creation Date:
2024-05-06 @ 3:19 PM
Last Modification Date:
2024-10-26 @ 1:47 PM
Study NCT ID:
NCT04597450
Status:
COMPLETED
Last Update Posted:
2023-03-24
First Post:
2020-10-02
Brief Title:
Lu AG06466 in Participants With Post Traumatic Stress Disorder PTSD
Sponsor:
H Lundbeck AS
Organization:
H Lundbeck AS
Study Overview
Official Title:
Interventional Randomized Double-Blind Crossover Placebo-Controlled Exploratory Study Investigating the Effects of Lu AG06466 on BOLD fMRI Signals and Sleep Parameters in Patients With PTSD
Status:
COMPLETED
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate the effect of Lu AG06466 after multiple doses of 30 milligrams mg in participants with PTSD
Detailed Description:
The crossover study consists of two treatment periods of 15 days duration On Day -1 or Day 1 of Treatment Period 1 eligible participants will be randomized 11 to a sequence of treatments either Lu AG06466-placebo or placebo-Lu AG06466 with 15 participants are planned per sequence Each treatment period will be separated by a washout period of 7 and 14 days
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None